Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Stable Ligand Coordination at the Surface of Colloidal CsPbBr3 Nanocrystals.

Quarta D, Imran M, Capodilupo AL, Petralanda U, van Beek B, De Angelis F, Manna L, Infante I, De Trizio L, Giansante C.

J Phys Chem Lett. 2019 Jul 5;10(13):3715-3726. doi: 10.1021/acs.jpclett.9b01634. Epub 2019 Jun 21.

PMID:
31244273
2.

How do morphological alterations caused by chronic pain distribute across the brain? A meta-analytic co-alteration study.

Tatu K, Costa T, Nani A, Diano M, Quarta DG, Duca S, Apkarian AV, Fox PT, Cauda F.

Neuroimage Clin. 2017 Dec 21;18:15-30. doi: 10.1016/j.nicl.2017.12.029. eCollection 2018.

3.

Promotion of safety culture in Italian schools: effectiveness of interventions on student injuries.

Bena A, Farina E, Orengia M, Quarta D.

Eur J Public Health. 2016 Aug;26(4):587-92. doi: 10.1093/eurpub/ckw039. Epub 2016 Apr 19.

PMID:
27095793
4.

Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission.

Quarta D, Smolders I.

Eur J Pharm Sci. 2014 Jun 16;57:2-10. doi: 10.1016/j.ejps.2014.01.008. Epub 2014 Jan 25. Review.

PMID:
24472703
5.

Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine.

Quarta D, Naylor CG, Glennon JC, Stolerman IP.

Behav Pharmacol. 2012 Apr;23(2):143-52. doi: 10.1097/FBP.0b013e32834f9fb4.

PMID:
22193593
6.

The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.

Large CH, Bison S, Sartori I, Read KD, Gozzi A, Quarta D, Antolini M, Hollands E, Gill CH, Gunthorpe MJ, Idris N, Neill JC, Alvaro GS.

J Pharmacol Exp Ther. 2011 Jul;338(1):100-13. doi: 10.1124/jpet.110.178475. Epub 2011 Apr 12.

PMID:
21487071
7.

The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.

Halbout B, Quarta D, Valerio E, Heidbreder CA, Hutcheson DM.

Addict Biol. 2011 Jul;16(3):416-27. doi: 10.1111/j.1369-1600.2010.00278.x. Epub 2011 Feb 11.

PMID:
21309927
8.

Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward.

Hutcheson DM, Quarta D, Halbout B, Rigal A, Valerio E, Heidbreder C.

Behav Pharmacol. 2011 Apr;22(2):173-81. doi: 10.1097/FBP.0b013e328343d761.

PMID:
21285875
9.

Increased phasic activity of VTA dopamine neurons in mice 3 weeks after repeated social defeat.

Razzoli M, Andreoli M, Michielin F, Quarta D, Sokal DM.

Behav Brain Res. 2011 Mar 17;218(1):253-7. doi: 10.1016/j.bbr.2010.11.050. Epub 2010 Dec 1.

PMID:
21129410
10.

Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.

Justinová Z, Ferré S, Redhi GH, Mascia P, Stroik J, Quarta D, Yasar S, Müller CE, Franco R, Goldberg SR.

Addict Biol. 2011 Jul;16(3):405-15. doi: 10.1111/j.1369-1600.2010.00258.x. Epub 2010 Nov 4.

11.

Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats.

Quarta D, Large CH.

J Psychopharmacol. 2011 Dec;25(12):1703-11. doi: 10.1177/0269881110385598. Epub 2010 Nov 1.

PMID:
21041417
12.

Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas.

Quarta D, Leslie CP, Carletti R, Valerio E, Caberlotto L.

Neuropharmacology. 2011 Feb-Mar;60(2-3):328-35. doi: 10.1016/j.neuropharm.2010.09.016. Epub 2010 Sep 22.

PMID:
20868698
13.

Risk factors for upper extremity musculoskeletal symptoms among call center employees.

d'Errico A, Caputo P, Falcone U, Fubini L, Gilardi L, Mamo C, Migliardi A, Quarta D, Coffano E.

J Occup Health. 2010;52(2):115-24. Epub 2010 Feb 23.

14.

[Evaluation of the effectiveness of occupational safety and health inspections of construction sites in the Piedmont region from 2001 to 2005].

Bruno S, Bena A, Debernardi ML, Nava S, Pastore R, Proietti C, Quarta D.

Med Lav. 2009;100 Suppl 1:7-10. Italian.

PMID:
19848093
15.

The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.

Quarta D, Valerio E, Hutcheson DM, Hedou G, Heidbreder C.

Neurochem Int. 2010 Jan;56(1):11-5. doi: 10.1016/j.neuint.2009.08.012. Epub 2009 Sep 6.

PMID:
19737591
16.

Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens.

Quarta D, Di Francesco C, Melotto S, Mangiarini L, Heidbreder C, Hedou G.

Neurochem Int. 2009 Feb;54(2):89-94. doi: 10.1016/j.neuint.2008.12.006. Epub 2008 Dec 11.

PMID:
19118592
17.

[Working conditions and health problems among call-centre operators: a study on self-reported data in the Piedmont Region (Italy)].

Gilardi L, Fubini L, d'Errico A, Falcone U, Mamo C, Migliardi A, Quarta D, Coffano ME.

Med Lav. 2008 Nov-Dec;99(6):415-23. Italian.

PMID:
19086614
18.

Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.

Quarta D, Naylor CG, Barik J, Fernandes C, Wonnacott S, Stolerman IP.

Psychopharmacology (Berl). 2009 Apr;203(2):399-410. doi: 10.1007/s00213-008-1281-x. Epub 2008 Aug 30.

PMID:
18758759
19.

[Injury rates and severity during the construction of High Speed Train Track Torino-Novara: which are the expected risks?].

Bena A, Debernardi ML, Pasqualini O, Dalmasso M, Quarta D.

Med Lav. 2008 May-Jun;99(3):177-86. Italian.

PMID:
18689089
20.

Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.

Ferre S, Ciruela F, Borycz J, Solinas M, Quarta D, Antoniou K, Quiroz C, Justinova Z, Lluis C, Franco R, Goldberg SR.

Front Biosci. 2008 Jan 1;13:2391-9. Review.

PMID:
17981720
21.

Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.

Quarta D, Naylor CG, Morris HV, Patel S, Genn RF, Stolerman IP.

Neuropharmacology. 2007 Sep;53(3):421-30. Epub 2007 Jun 7.

PMID:
17631918
22.

The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination.

Quarta D, Naylor CG, Stolerman IP.

Psychopharmacology (Berl). 2007 Aug;193(3):391-402. Epub 2007 May 1.

PMID:
17473916
23.

Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release.

Quarta D, Ciruela F, Patkar K, Borycz J, Solinas M, Lluis C, Franco R, Wise RA, Goldberg SR, Hope BT, Woods AS, Ferré S.

Neuropsychopharmacology. 2007 Jan;32(1):35-42. Epub 2006 May 17.

24.

[Differences of perceived health and lifestyle by occupational groups in the Italian ISTAT (Central Statistic Institute) health survey].

Vannoni F, Demaria M, Quarta D, Gargiulo L, Costa G.

Med Lav. 2005;96 Suppl:s66-84. Italian.

PMID:
15871619
25.

[Healthy life expectancy in the occupied segment of the Turin population].

Spadea T, Quarta D, Demaria M, Marinacci C, Costa G.

Med Lav. 2005;96 Suppl:s28-38. Italian.

PMID:
15871616
26.

Tolerance to nicotine in mice lacking alpha7 nicotinic receptors.

Naylor C, Quarta D, Fernandes C, Stolerman IP.

Psychopharmacology (Berl). 2005 Jul;180(3):558-63. Epub 2005 Feb 19.

PMID:
15723228
27.

Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats.

Solinas M, Ferré S, Antoniou K, Quarta D, Justinova Z, Hockemeyer J, Pappas LA, Segal PN, Wertheim C, Müller CE, Goldberg SR.

Psychopharmacology (Berl). 2005 May;179(3):576-86. Epub 2005 Feb 5.

PMID:
15696333
28.

Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.

Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S.

J Neurochem. 2004 Nov;91(4):873-80.

29.
30.

Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos.

Karcz-Kubicha M, Quarta D, Hope BT, Antoniou K, Müller CE, Morales M, Schindler CW, Goldberg SR, Ferré S.

Eur J Neurosci. 2003 Jul;18(2):296-302.

PMID:
12887411
31.

Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.

Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, Pezzola A, Reggio R, Müller CE, Fuxe K, Goldberg SR, Popoli P, Ferré S.

Neuropsychopharmacology. 2003 Jul;28(7):1281-91. Epub 2003 Apr 9.

32.

Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M.

J Neurosci. 2002 Mar 1;22(5):1967-75.

33.

SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.

Pintor A, Quarta D, Pèzzola A, Reggio R, Popoli P.

Eur J Pharmacol. 2001 Jun 15;421(3):177-80.

PMID:
11516434
34.

The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors.

Pintor A, Pèzzola A, Reggio R, Quarta D, Popoli P.

Neuroreport. 2000 Nov 9;11(16):3611-4.

PMID:
11095529

Supplemental Content

Loading ...
Support Center